Effects of starting cellular material composition on chimeric antigen receptor T‐cell expansion and characteristics-Reference-Cited by-同舟云学术

Effects of starting cellular material composition on chimeric antigen receptor T‐cell expansion and characteristics

Published:2019-04-11 Issue:5 Volume:59 Page:1755-1764
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Elavia Nasha¹²,Panch Sandhya R.¹²,McManus Andrew¹²,Bikkani Thejaswi¹²,Szymanski James¹²,Highfill Steven L.¹²,Jin Ping¹²,Brudno Jennifer³,Kochenderfer James³,Stroncek David F.¹²

Affiliation:

1. Department of Transfusion MedicineNational Institutes of Health Clinical Center Bethesda Maryland

2. Center for Cellular EngineeringNational Institutes of Health Clinical Center Bethesda Maryland

3. Experimental Transplantation and Immunology BranchNational Cancer Institute and National Institutes of Health Bethesda Maryland

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.15287

Reference21 articles.

1. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

2. Intent‐to‐treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults;Gardner RA;Blood,2017

3. Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

4. CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy

5. T cells expressing an anti–B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LYMPHOCYTE ANALYSIS OF APHERESIS PRODUCTS INVOLVED IN CAR-T CELL MANUFACTURING FAILURE;Japanese Journal of Transfusion and Cell Therapy;2024-06-25

2. Enrichment of T-lymphocytes from leukemic blood using inertial microfluidics toward improved chimeric antigen receptor-T cell manufacturing;Cytotherapy;2024-05

3. INSPIRED Symposium Part 4B: Chimeric Antigen Receptor T Cell Correlative Studies—Established Findings and Future Priorities;Transplantation and Cellular Therapy;2024-02

4. Early predictive factors of failure in autologous CAR T-cell manufacturing and/or efficacy in hematologic malignancies;Blood Advances;2024-01-11

5. Development of a highly cytotoxic, clinical-grade virus-specific T cell product for adoptive T cell therapy;Cellular Immunology;2024-01